Novavax Inc (NVAX) Financials
Key financial figures for Novavax Inc (Q2 2026).
Novavax, Inc. reported revenue of $56.7 million for Q2 FY2026, down 76.3% from the same period a year earlier. The company posted a net loss of $53.4 million, or -$0.32 per share. Operating margin came to -96.84%, against 44.17% a year earlier. Across the last 5 reported quarters, quarterly revenue has moved from $239.2 million in Q2 FY2025 to $56.7 million in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Novavax, Inc. are on the SentiSense financials page.
- Revenue
- $57M
- Net Income
- -$53M
- EPS
- $-0.32
- Total Assets
- $956M
- Operating Cash Flow
- -$75M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $57M | -$53M | -$0.32 | -96.84% | |
| Q1 FY2026 | $140M | -$9M | -$0.06 | -11.06% | -$34M |
| Q4 FY2025 | $147M | $18M | $0.11 | 14.29% | -$42M |
| Q3 FY2025 | $70M | -$202M | -$1.25 | -252.7% | $106M |
| Q2 FY2025 | $239M | $107M | $0.62 | 44.17% | -$128M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $1.1B | $440M | $2.58 | 50.14% | -$250M |
| FY2024 | $682M | -$187M | -$1.23 | -36.49% | -$100M |
| FY2023 | $556M | -$545M | -$5.41 | -101.82% | -$773M |
Frequently asked questions
What was Novavax, Inc.'s revenue last quarter?
Novavax, Inc. reported revenue of $56.7 million for Q2 FY2026, down 76.3% from the same period a year earlier.
Is Novavax, Inc. profitable?
Not in its most recent reported period. Novavax, Inc. reported a net loss of $53.4 million for Q2 FY2026, a net margin of -94.16% on revenue.
How has Novavax, Inc.'s margin trended?
Operating margin was -96.84% in Q2 FY2026, compared with 44.17% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How many quarters of Novavax, Inc. financials does SentiSense hold?
SentiSense holds up to forty quarters and twenty fiscal years of income statement, balance sheet and cash flow history for NVAX. The 5 most recent quarters are summarised above.
Full income statement, balance sheet and cash flow for Novavax Inc on SentiSense, with up to forty quarters and twenty fiscal years of history.